Dr Sofia Bartlett – Molecular epidemiology of recently acquired hepatitis C virus infection in Australia

Date Published: 
14 November 2017
Target Sites: 
Medicine (select for all events)
Medicine Staff Website (select for events only)
The Kirby Institute (Decoupled. Publishing not working any more.)
Digital Signage (Select for all Randwick/Kensington based events)
image - KI SS FB Preview1 2
Event date: 
21 November 2017 - 1:00pm to 2:00pm
Location: 
Berg Family Foundation Seminar Room, Level 6, Wallace Wurth Building, Kensington Campus
Event Type: 
Seminar
Contact for inquiries: 
Rata Joseph, +61 (2) 9385 0900 or recpt@kirby.unsw.edu.au
Booking deadline: 
Body: 

Kirby Institute Seminar Series presents

Dr Sofia Bartlett

Dr Sofia Bartlett

Research Assistant, Viral Hepatitis Clinical Research Program, Kirby Institute


About your speaker

Sofia Bartlett recently completed her PhD with the Kirby Institute's Viral Hepatitis Clinical Research Program on recently acquired hepatitis C virus infection in Australia. Her research is multidisciplinary, utilising molecular biology laboratory techniques, phylogenetics and clinical epidemiology to study several elements of hepatitis C virus infection, such as transmission patterns, drug resistance and diagnostics. 

Abstract

Sofia will present an overview of the work that contributed to her recently completed PhD thesis. Her thesis aimed to identify transmission patterns among people with recent HCV infection in Australia. This included evaluation of factors associated with phylogenetic clustering; reconstructing transmission networks to model the effect of targeted HCV treatment; identification of multi-risk profiles associated with phylogenetic clustering of HCV; and identifying and evaluating methods for the detection of DAA resistance. Sofia hates scientific jargon and will try to avoid it as much as possible while explaining these phylogenetic studies.